Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial-Reference-Cited by-同舟云学术

Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

Published:2023-05 Issue:5 Volume:10 Page:e346-e358
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Melani Christopher,Dowdell Kennichi,Pittaluga Stefania,Dunleavy Kieron,Roschewski Mark,Song Joo Y,Calattini Sara,Kawada Jun-ichi,Price David A,Chattopadhyay Pratip K,Roederer Mario,Lucas Andrea N,Steinberg Seth M,Jaffe Elaine S,Cohen Jeffrey I,Wilson Wyndham H

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Hematology

Reference20 articles.

1. Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder;Melani;Blood,2020

2. Lymphomatoid granulomatosis—a single institute experience: pathologic findings and clinical correlations;Song;Am J Surg Pathol,2015

3. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-alpha 2b;Wilson;Blood,1996

4. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases;Katzenstein;Cancer,1979

5. Lymphomatoid granulomatosis. Prospective clinical and therapeutic experience over 10 years;Fauci;N Engl J Med,1982

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced Lymphomatoid Granulomatosis Involving the Central Nervous System and Lung Parenchyma Presenting with Speech and Gait Disturbances;Indian Journal of Hematology and Blood Transfusion;2024-09-05

2. Lymphomatoid granulomatosis mimicking PJP infection;BMJ Case Reports;2024-05

3. A long-awaited benchmark in lymphomatoid granulomatosis;The Lancet Haematology;2023-05